Jodi Grødem

Researcher with the group at the Norwegian Center for Movement Disorders. Traveller, hiker and supporter of too many sports to list

[Jodi Grødem @JoGrodem]

Grateful to @NorgesParkinson for an amazing event where we met so many people involved with Parkinson’s in Norway, including patients and advocates 🏆 and people working to make the Norwegian Parkinson’s Registry and ParkinsonNet Norway so successful 🙌

[Jodi Grødem @JoGrodem]

It was incredible to be part of the group of volunteers at #WPC2023

[Jodi Grødem @JoGrodem]

Thank you to everyone who stayed around to hear about our newest GCase results and to @mc_gonzalez_MD for the support! Go team @ParkinsonNKB !

[Maria Camila Gonzalez @mc_gonzalez_MD]

Feeling really inspired after my supervisor Dr. Jodi Maple-Grødem's presentation on GCASE activity and the LONG-TERM RISK of cognitive decline in PD. #adpd23 @ParkinsonNKB

[Alexander Rothkopf @rothkopfAK]

This morning it is a pleasure to serve as external committee member for a postdoc position at @UniStavanger at @MitoRem’s lab. Transparency in hiring crucial in the Nordics. With @EmielJanssen7 & @JoGrodem at #Måltidetshus.

[Jodi Grødem @JoGrodem]

The summer school that had it all! A great week spent learning and discussing how the health of people is closely connected to the health of animals and our shared environment #NORBRA2022 #onehealth

[Jodi Grødem @JoGrodem]

Exciting to be joined by students from Brazil and Norway for the One Health school this week #norbra2025 #onehealth

[NKB @ParkinsonNKB]

It is great to be back in person for the annual ParkWest meeting, bringing together some of the people who make the Norwegian ParkWest study possible and hearing about the exciting work coming from this diverse team! #Parkinsons

[NKB @ParkinsonNKB]

Congratulations to our team at @ParkinsonNKB on the publication of exciting work showing that CSF GCase activity at PD diagnosis is linked to the future risk of dementia. These results could have important implications for #clinicaltrials in #parkinsons https://t.co/F6ou20uaj2

[NKB @ParkinsonNKB]

The #MDSCongress in Madrid may be over, but it’s still possible to see @ParkinsonNKB posters online – go check out abstract numbers 48, 1197 and 1319! #MDS2022
https://t.co/TwrGFHRNC2

[Jodi Grødem @JoGrodem]

A great meeting with participants from more than 50 countries – GP2 is truly transforming the way we study the genetics of Parkinson’s! #gp2aim2022

[Jodi Grødem @JoGrodem]

Helping patients in Norway to have a strong voice - @NorgesParkinson have outlined how patients can now register themselves in the Norwegian Parkinson's registry and contribute directly to this important initiative (article in Norwegian) https://t.co/ucdodQOVgP

[NKB @ParkinsonNKB]

NKB is incredibly proud to reveal that patients can now choose to register themselves in the Norwegian Parkinson registry using a QR code – read what the coordinator, Eldbjørg Fiske, says about this exciting development in @DagensMedisin @NorgesParkinson https://t.co/tLUuxJcBMC

[Jodi Grødem @JoGrodem]

Excited to be representing the team @ParkinsonNKB at #AAIC22 in San Diego today (Wednesday). About to take to the stage to talk about our work on the enzyme GCase and the risk of dementia in Parkinson’s disease!

[Jodi Grødem @JoGrodem]

Amazing morning for the #AAIC22 5k run to #ENDALZ Congrats to all those who joined in - what a way to start a big day of science!